Related Experiment Videos
Molecular prognostic markers in breast cancer
1Department of Urology and Medicine, University of California at San Francisco, and VA Medical Center, 94121, USA. Urologylab@aol.com
Breast Cancer Research and Treatment
|March 5, 1999
Summary
Several molecular markers, including BRCA-1/2 and p53, show potential for breast cancer prognosis. Understanding these biomarkers can improve patient outcomes and treatment strategies for breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer prognosis relies on accurate prediction of disease progression.
- Identifying reliable molecular markers is crucial for personalized treatment strategies.
Purpose of the Study:
- To review and discuss the potential role of various molecular markers in breast cancer prognosis.
- To consolidate information on biomarkers such as BRCA-1, BRCA-2, p53, and others.
Main Methods:
- Literature review of scientific publications on breast cancer molecular markers.
- Analysis of data concerning the prognostic significance of identified markers.
Main Results:
- Several molecular markers demonstrate potential prognostic value in breast cancer.
- Key markers include BRCA-1, BRCA-2, p53, erbB oncogenes, LOH, chromosomal aberrations, microsatellite instability, TGFalpha, and MDR gene.
Conclusions:
- The discussed molecular markers may play a significant role in predicting breast cancer outcomes.
- Further research can validate these markers for clinical application in breast cancer management.